Orionis Biosciences is based in Waltham, Massachusetts. It has raised $85M in total funding. Latest round: Series C.
Orionis Biosciences is based in Waltham, Massachusetts. Orionis Biosciences has raised $85M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in October 2022. The round record for Orionis Biosciences runs through 2022; nothing later has been disclosed. Investors on record include Cormorant Asset Management, Novartis, Cascade Investment, Genentech, V-Bio Ventures, Excel Venture Management and 1 others. 7 distinct backers are named across the disclosed rounds.
Round data for Orionis Biosciences is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Waltham and backer lists below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026